Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Altor BioScience
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center
Herlev Hospital